Moderate to Severe Acne Pipeline Landscape Analysis, 2024, Featuring Emerging Therapies ASC40 (Ascletis Pharma), BTX 1503 (Botanix Pharmaceuticals), and More
ASCArdmore Shipping(ASC) GlobeNewswire News Room·2024-06-06 22:56

Dublin, June 06, 2024 (GLOBE NEWSWIRE) -- The "Moderate to Severe Acne - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering. The global therapeutic market is on the cusp of transformation as novel insights emerge in the pipeline landscape for Moderate to Severe Acne treatment. This is highlighted in a current comprehensive report, focusing on the trajectory of research and development efforts in this domain. Disclosed within this report are the ambitious endeavors of 10+ phar ...